scispace - formally typeset
H

Hengte Ke

Researcher at Soochow University (Suzhou)

Publications -  57
Citations -  4581

Hengte Ke is an academic researcher from Soochow University (Suzhou). The author has contributed to research in topics: Photothermal therapy & Chemistry. The author has an hindex of 30, co-authored 48 publications receiving 3726 citations. Previous affiliations of Hengte Ke include Peking University & Harbin Institute of Technology.

Papers
More filters
Journal ArticleDOI

Size-Dependent Ag2S Nanodots for Second Near-Infrared Fluorescence/Photoacoustics Imaging and Simultaneous Photothermal Therapy

TL;DR: Size-dependent Ag2S nanodots with well-defined nanostructure with ideal resistance to photobleaching, effective cellular uptake, preferable tumor accumulation, and in vivo elimination are reported, facilitating NIR-II fluorescence/photoacoustics imaging with both ultrasensitivity and microscopic spatial resolution and simultaneous photothermal tumor ablation.
Journal ArticleDOI

Gold‐Nanoshelled Microcapsules: A Theranostic Agent for Ultrasound Contrast Imaging and Photothermal Therapy

TL;DR: A novel multifunctional theranostic agent based on gold-nanoshelled microcapsules (GNS-MCs) is developed by electrostatic adsorption of gold nanoparticles as seeds onto the polymeric microcapsule surfaces, followed by the formation of gold nanoshells by using a surface seeding method.
Journal ArticleDOI

Smart Albumin-Biomineralized Nanocomposites for Multimodal Imaging and Photothermal Tumor Ablation.

TL;DR: Smart cyanine-grafted gadolinium oxide nanocrystals obtained by albumin-based biomineralization are shown to be theranostic nanocomposites, with promising properties for trimodal near-infrared fluorescence/photoacoustics/magnetic-resonance imaging-guided photothermal tumor ablation.
Journal ArticleDOI

Ultrastable Near-Infrared Conjugated-Polymer Nanoparticles for Dually Photoactive Tumor Inhibition

TL;DR: CP‐NPs achieve photoactive cell damage through their photoconversion ability for synergistic PDT/PTT treatment with tumor ablation, thus promoting severe light‐triggered damage caused by favorable reactive oxygen species (ROS) generation and potent hyperthermia.